SELL Glenmark Pharmaceuticals — ICICI Securities, 19 Aug 2025

SELLGlenmark Pharmaceuticals

Glenmark Pharmaceuticals share price target & all analyst calls

byICICI SecuritiesHorizon: NA (inferred 1 year)19 Aug 2025via Institutional / Brokerage Research

Entry₹1,945.8Inferred

Target₹1,570

Total upside +19.31%

Stop lossNot given

At expiry₹2,246.519 Aug 2026, 3:30 pm

Expired-15.45%auction close

Follow ICICI Securities for new calls(67% target hit, 1026 closed calls)Get alerts Watch GLENMARK for new buy/sell callsGet alerts See 5 active Long-term calls on GLENMARK See 211 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 19 Aug 2026

1 supporting6 neutral15 opposing

Supports the SELL call (1)

Glenmark Pharma US arm agrees to $15.28 million settlement with Humana over antitrust lawsuits

NewsCnbc-Tv18·12 Aug · 1w ago

Neutral / worth noting (6)

Glenmark USA has agreed to a settlement of $15.28 million to resolve antitrust and consumer protection lawsuits related to price-fixing allegations. The company denies all allegations and states the s

BSE · Company Update·11 Aug · 1w ago

Glenmark Pharma Q1 FY27 Results and Brokerage Outlook

NewsGoogle News·4 Aug · 2w ago

Glenmark Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·31 Jul · 3w ago

The Board of Directors has considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026

BSE · Board Meeting·31 Jul · 3w ago

Weighs against the SELL call (15)

Glenmark Pharma Q1 Revenue Beats Estimates, EBITDA Margins Seen Rising

NewsGoogle News·4 Aug · 2w ago

Glenmark Pharma's India-US Growth Story Intact, Says Motilal Oswal, Maintaining 'Buy' — Check Target Price

NewsNdtv-Profit·4 Aug · 2w ago

2 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·4 Aug · 2w ago

Glenmark Pharma Q1 profit jumps over 10-fold as India, North America businesses power growth

NewsCnbc-Tv18·31 Jul · 3w ago

Glenmark Pharma Q1 Results: Profit Rises Exponentially To Rs 483 Crore; Revenue Jumps 23%

NewsNdtv-Profit·31 Jul · 3w ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Glenmark Pharmaceuticals

All analyst calls on Glenmark Pharmaceuticals

More from ICICI Securities

Every call and its outcome